Implementing hexaminolevulinate HCl blue light cystoscopy: a nursing perspective.
Publication/Presentation Date
11-1-2014
Abstract
Hexaminolevulinate HCl is a diagnostic imaging agent used with blue light during cystoscopy to help detect non-muscle-invasive bladder cancer. Blue light cystoscopy performed using hexaminolevulinate HCl has been found to detect more papillary non-muscle-invasive bladder tumors than cystoscopy performed using standard white light. Because bladder instillation and retention requirements of hexaminolevulinate during cystoscopy can affect patient flow in the perioperative setting, this technique necessitates changes in nursing practice and care of patients with known or suspected non-muscle-invasive bladder cancer. Nursing personnel at one facility followed the AORN guidelines for preoperative patient care in the ambulatory setting to address staffing, preoperative nursing assessment, anesthesia evaluation, and preoperative teaching related to implementing blue light cystoscopy.
Volume
100
Issue
5
First Page
489
Last Page
496
ISSN
1878-0369
Published In/Presented At
Calvaresi, A. E., Trabulsi, E. J., Sonzogni, M., Gomella, L. G., Lallas, C. D., & Wachsmuth, K. S. (2014). Implementing hexaminolevulinate HCl blue light cystoscopy: a nursing perspective. AORN journal, 100(5), 489–499. https://doi.org/10.1016/j.aorn.2013.12.013
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
25443119
Department(s)
Administration and Leadership
Document Type
Article